In 2013 and 2014, Colorado, Missouri, and Louisiana passed “right-to-try” laws that permit manufactures to provide experimental medicines to terminally ill patients without US FDA authorization. US FDA currently has a process by which patients can access experimental drugs through "expanded access" or "compassionate use" Compassionate use refers to the use of an investigational new drug outside of a clinical trial by patients with serious or life-threatening conditions( HIV/AIDS, cancer, rare diseases) who do not meet the enrollment criteria for the clinical trial in progress. It allows access only to medications that have passed manufacturers’ Phase I clinical trials.
Access limited to use by terminally ill patients who have exhausted other available treatments. Laws require that the treating physician recommend the experimental therapy, and the Colorado and Louisiana statutes further…
